Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases

SIMPLE SUMMARY: Approximately 20% of patients with cancer develop brain metastases (BM). Early BM diagnosis is critical to enable less invasive or toxic approaches. Sensitive and easy-to-use blood-based BM biomarkers may allow early diagnosis and appropriate timely treatment and may improve overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su-Hyun, Gwak, Ho-Shin, Lee, Youngjoo, Park, Na-Young, Han, Mira, Kim, Yeseul, Kim, So-Yeon, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125258/
https://www.ncbi.nlm.nih.gov/pubmed/34066445
http://dx.doi.org/10.3390/cancers13092227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125258/
https://www.ncbi.nlm.nih.gov/pubmed/34066445
http://dx.doi.org/10.3390/cancers13092227

Ejemplares similares